Theory Background: Acute viral upper respiratory infection is a most common clinic infective disease, and about 70%-80% of it is caused by virus.
理论背景急性上呼吸道感染是临床最常见的一种感染性疾病，约有70% - 80%由病毒引起。
Acute laryngitis is caused by a viral infection, usually linked to the common cold or an upper respiratory infection.
急性喉炎是所造成的病毒感染，通常是联系在一起的普通感冒或上呼吸道感染。
AIM: to evaluate the therapeutic effects and safety of ribavirin glucose injection and ribavirin (Virazole) injection in the treatment of acute viral upper respiratory tract infection.
目的：评价利巴韦林葡萄糖注射液对急性病毒性上呼吸道感染的疗效及安全性并与利巴韦林注射液进行比较。
应用推荐